PodParley PodParley
PodParley
FCR vs. BR - Is One Better? episode artwork

EPISODE · Aug 26, 2016 · 4 MIN

FCR vs. BR - Is One Better?

from GRACEcast · host cancerGRACE Meetings

Jennifer Brown, MD, discusses the choice in chemoimmunotherapy, FCR (fludarabine, cyclophosphamide and rituximab) vs BR. FCR has been the standard therapy for previously untreated fit patients with CLL under about the age of 70. While BR (bendamustine and rituximab), is a relatively newer therapy, which had been studied in a couple of phase two trials - smaller single arm trials and look to be promising.

Episode metadata supplied by the publisher feed · Published Aug 26, 2016

What this episode covers

Jennifer Brown, MD, discusses the choice in chemoimmunotherapy, FCR (fludarabine, cyclophosphamide and rituximab) vs BR. FCR has been the standard therapy for previously untreated fit patients with CLL under about the age of 70. While BR (bendamustine and rituximab), is a relatively newer therapy, which had been studied in a couple of phase two trials - smaller single arm trials and look to be promising.

PodParley-generated summary based on available episode metadata and transcript content.

NOW PLAYING

FCR vs. BR - Is One Better?

0:00 4:23

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

2 | God’s Covenant of Help

Jul 2, 2026 ·56m

Protect Your Peace

Jul 1, 2026 ·43m

Good for Good Sake

Jun 28, 2026 ·8m

1 | The Power of the Blood

Jun 25, 2026 ·61m

10 | Reporting for Duty

Jun 24, 2026 ·51m

Identity, Power and Peacemaking

Jun 21, 2026 ·15m

Similar Podcasts

GRACEcast Radiation Oncology Video cancerGRACE - H. Jack West, MD Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care. GRACEcast - Discussions with the Global Resource for Advancing Cancer Education cancerGRACE In this podcast series, the Global Resource for Advancing Cancer Education (GRACE) works to bring professionals together with patients and caregivers to work in partnership. We interview patients, advocates and healthcare professionals to provide the most updated information for our community and to highlight important issues facing those dealing with a cancer diagnosis. For more information visit www.cancerGRACE.org. To join the conversation, visit https://cancergrace.org/forums Gracecasts – Grace Bible Church Pastor Mark Totten Gracecast (podcast) are messages from Grace Bible Church of Clarksville TN. GraceCast | Midweek Grace Fellowship | London GraceCast | Midweek features weekly adult Bible studies from Grace Fellowship Church in London, KY. ••For questions or comments, email: [email protected]. To learn more about Grace Fellowship Church, visit: www.graceforyou.com

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 4 minutes long.

When was this GRACEcast episode published?

This episode was published on August 26, 2016.

What is this episode about?

Jennifer Brown, MD, discusses the choice in chemoimmunotherapy, FCR (fludarabine, cyclophosphamide and rituximab) vs BR. FCR has been the standard therapy for previously untreated fit patients with CLL under about the age of 70. While BR...

Can I download this GRACEcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!